[go: up one dir, main page]

AR023062A1 - Formulaciones antiparasitarias - Google Patents

Formulaciones antiparasitarias

Info

Publication number
AR023062A1
AR023062A1 ARP990105840A ARP990105840A AR023062A1 AR 023062 A1 AR023062 A1 AR 023062A1 AR P990105840 A ARP990105840 A AR P990105840A AR P990105840 A ARP990105840 A AR P990105840A AR 023062 A1 AR023062 A1 AR 023062A1
Authority
AR
Argentina
Prior art keywords
antiparasitary
formulations
dialkylene
milbemycin
ectoparasites
Prior art date
Application number
ARP990105840A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10842728&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR023062(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of AR023062A1 publication Critical patent/AR023062A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017Non-human animal skin, e.g. pour-on, spot-on
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/14Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dentistry (AREA)
  • Organic Chemistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Una formulacion antiparasitaria de accion prolongada que es adecuada para su aplicacion por vía topica y que contiene: (a) un 0,1-50% p/v de unaavermectina o milbemicina que presenta actividad contra endoparásitos o ectoparásitos; (b) un 1-50% v/v deun éter monoalquílico (C1-4) de un dialquilen (C2-4)glicol; (c) un antioxidante opcional; y opcionalmente (d) un disolvente volátil q.s. v/v, tolerable por la piel.
ARP990105840A 1998-11-19 1999-11-17 Formulaciones antiparasitarias AR023062A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9825402.2A GB9825402D0 (en) 1998-11-19 1998-11-19 Antiparasitic formulations

Publications (1)

Publication Number Publication Date
AR023062A1 true AR023062A1 (es) 2002-09-04

Family

ID=10842728

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990105840A AR023062A1 (es) 1998-11-19 1999-11-17 Formulaciones antiparasitarias

Country Status (43)

Country Link
US (1) US6797701B2 (es)
EP (2) EP1522219B1 (es)
JP (1) JP3507799B2 (es)
KR (1) KR100458406B1 (es)
CN (1) CN1147232C (es)
AP (1) AP1210A (es)
AR (1) AR023062A1 (es)
AT (2) ATE469550T1 (es)
BG (1) BG65440B1 (es)
BR (1) BR9915458B1 (es)
CA (1) CA2351730C (es)
CO (1) CO5150175A1 (es)
CY (1) CY1111955T1 (es)
CZ (1) CZ304345B6 (es)
DE (2) DE69923583T3 (es)
DK (2) DK1130966T4 (es)
DZ (1) DZ2945A1 (es)
EA (1) EA003959B1 (es)
ES (2) ES2237213T3 (es)
GB (1) GB9825402D0 (es)
GT (1) GT199900197A (es)
HK (1) HK1040593B (es)
HR (1) HRP20010368B1 (es)
HU (1) HU229493B1 (es)
ID (1) ID28698A (es)
IL (3) IL142104A0 (es)
IS (1) IS5907A (es)
MA (1) MA25029A1 (es)
NO (1) NO20012389L (es)
NZ (2) NZ510678A (es)
OA (1) OA11678A (es)
PA (1) PA8485501A1 (es)
PE (1) PE20001319A1 (es)
PL (1) PL204763B1 (es)
PT (2) PT1130966E (es)
SI (2) SI1130966T2 (es)
SK (1) SK287540B6 (es)
TN (1) TNSN99213A1 (es)
TW (1) TW526045B (es)
UY (1) UY25806A1 (es)
WO (1) WO2000030449A1 (es)
YU (1) YU23401A (es)
ZA (1) ZA997174B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2753377B1 (fr) 1996-09-19 1999-09-24 Rhone Merieux Nouvelle association parasiticide a base de 1-n-phenylpyra- zoles et de lactones macrocycliques endectocides
US6426333B1 (en) 1996-09-19 2002-07-30 Merial Spot-on formulations for combating parasites
US6998131B2 (en) 1996-09-19 2006-02-14 Merial Limited Spot-on formulations for combating parasites
GB9825402D0 (en) * 1998-11-19 1999-01-13 Pfizer Ltd Antiparasitic formulations
AU733095B3 (en) * 1999-09-22 2001-05-03 Ashmont Holdings Limited Sheep pour on
AUPQ441699A0 (en) 1999-12-02 2000-01-06 Eli Lilly And Company Pour-on formulations
GB0108485D0 (en) * 2001-04-04 2001-05-23 Pfizer Ltd Combination therapy
US20030064941A1 (en) * 2001-05-21 2003-04-03 Pfizer Inc. Avermectin and praziquantel combination therapy
CN100344234C (zh) 2001-09-17 2007-10-24 伊莱利利公司 杀虫制剂
KR100600402B1 (ko) * 2002-05-22 2006-07-14 주식회사 엘지생명과학 피부 도포용 이버멕틴 조성물 및 그 제조방법
US20040151759A1 (en) * 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
US20040037869A1 (en) * 2002-08-16 2004-02-26 Douglas Cleverly Non-animal product containing veterinary formulations
US7666444B2 (en) * 2004-02-02 2010-02-23 Wyeth Antiparasitic composition
DE102004053964A1 (de) * 2004-11-09 2006-05-11 Bayer Healthcare Ag Mittel gegen Demodikose
GB2444572B (en) * 2006-12-05 2011-10-19 Michael Hilary Burke A process for the preparation of a stable anhydrous anthelmintic formulation
JP2012517994A (ja) * 2009-02-16 2012-08-09 ファイザー・インク 高投与量ドラメクチン製剤
EP2416663A2 (en) 2009-03-18 2012-02-15 Martin Benedict George Donnelly Parasiticidal formulation
UA108641C2 (uk) 2010-04-02 2015-05-25 Паразитицидна композиція, яка містить чотири активних агенти, та спосіб її застосування
BRPI1002174A2 (pt) * 2010-06-17 2012-03-13 Rotam Agrochem International Company Ltd Composição agroquímica, uso de um éter c2-c4 dialquileno glicol di-/mono-c1-c4 aquil, método para reduzir irritação ocular de formulações inseticidas líquidas, método de tratamento de praga em loco e uso da composição
EP3682887A1 (en) * 2010-07-30 2020-07-22 Ceva Sante Animale Compositions comprising ivermectin for treating heartworm infestation
US8901090B2 (en) 2010-10-20 2014-12-02 Galderma S.A. Method of treating otitis externa using macrocyclic lactone compound
IT1403631B1 (it) * 2011-01-14 2013-10-31 Gsi Geosyntec Invest B V Metodo e dispositivo per la posa e il tensionamento di una copertura impermeabile, per opere idrauliche in materiale sciolto.
BG1461U1 (bg) * 2011-03-18 2011-07-29 "Ендектовет" Еоод Състави за противопаразитно лекарствено средство
BRPI1104180A2 (pt) * 2011-08-25 2013-08-13 Eurofarma Lab Ltda composiÇÕes veterinÁrias pour on nço residuais, uso, kit, e mÉtodo de tratamento de parasitoses
BR112014009406A2 (pt) * 2011-10-18 2017-04-18 Agronomique Inst Nat Rech uso de derivados de avermectina para aumentar a biodisponibilidade e eficácia de lactonas macrocíclicas
AU2012345813B2 (en) 2011-12-02 2017-02-02 Boehringer lngelheim Vetmedica GMBH Long-acting injectable moxidectin formulations and novel moxidectin crystal forms
SG11201406278PA (en) * 2012-04-04 2014-11-27 Syngenta Participations Ag Pesticidal composition
AR094882A1 (es) 2013-02-26 2015-09-02 Zoetis Llc Selamectina para el tratamiento de las infestaciones por piojos de mar, composición
US20160081986A1 (en) * 2013-05-20 2016-03-24 Zoetis Services Llc Long-acting spiro-isoxazoline antiparasitic compositions
WO2018167271A1 (en) 2017-03-17 2018-09-20 Krka, D.D., Novo Mesto Stable topical veterinary composition
WO2019101961A1 (en) * 2017-11-23 2019-05-31 Ceva Sante Animale Composition containing moxidectin for treating parasites infestations
CN119174758A (zh) 2017-12-15 2024-12-24 塔苏斯制药有限公司 用于治疗睑炎的异恶唑啉驱虫剂制剂和方法

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4914624A (es) * 1972-06-08 1974-02-08
US3839234A (en) 1973-01-26 1974-10-01 C Roscoe Multi-purpose cleaning concentrate
SE434277B (sv) * 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4206205A (en) 1977-10-03 1980-06-03 Merck & Co., Inc. Monosaccharide and aglycone derivatives of C-076
GB2095107A (en) * 1981-03-24 1982-09-29 Janssen Pharmaceutica Nv Tetramisole-or levamisole pour-on compositions
PT80577B (pt) * 1984-06-05 1987-09-18 American Cyanamid Co Processo para a producao de novos agentes macrolidos ll-f28249 uteis no tratamento de infeccoes helminticas por ectoparasitas artropodes e por acarideos
DE3587294T2 (de) 1985-01-22 1993-09-30 Saint Gobain Vitrage Verfahren zur Herstellung einer dünnen Metalloxidbeschichtung auf einem Substrat, insbesondere Glas und deren Verwendung als Verglasung.
ES8800986A1 (es) * 1985-07-27 1987-12-01 Pfizer Un procedimiento para la produccion de un nuevo derivado de avermectina
DE3545529A1 (de) 1985-12-20 1987-07-02 Autotyp Sa Schneekette fuer fahrzeugraeder
LU86393A1 (fr) 1986-04-16 1987-12-07 Oreal Composition anti-acneique stable a base d'erythromycine
DE3750495T2 (de) * 1986-07-24 1995-02-23 Beecham Group Plc Milbemycin-Derivate mit parasitenabtötender Aktivität, ein Verfahren zu ihrer Herstellung und die sie enthaltenden Zusammensetzungen.
IL85119A (en) * 1987-01-23 1993-01-14 Pfizer Streptomyces avermitilis strains, their preparation and use in production of avermectins
DE3727648A1 (de) 1987-08-19 1989-03-02 Bayer Ag Neue avermectin derivate, verfahren zu ihrer herstellung und ihre verwendung
GB8721647D0 (en) * 1987-09-15 1987-10-21 Pfizer Ltd Antiparasitic agents
GB8726730D0 (en) * 1987-11-14 1987-12-16 Pfizer Ltd Antiparasitic agents
GB8804440D0 (en) * 1988-02-25 1988-03-23 Pfizer Ltd Antiparasitic agents
GB8807280D0 (en) * 1988-03-26 1988-04-27 Pfizer Ltd Antiparasitic agents
FR2630576B1 (fr) * 1988-04-26 1990-08-17 Realisations Nucleaires Et Dispositif d'amelioration de la duree de vie et de la fiabilite d'un tube neutronique scelle a haut flux
GB8815967D0 (en) 1988-07-05 1988-08-10 Pfizer Ltd Antiparasitic agents
US5015630A (en) 1989-01-19 1991-05-14 Merck & Co., Inc. 5-oxime avermectin derivatives
US4973468A (en) 1989-03-22 1990-11-27 Cygnus Research Corporation Skin permeation enhancer compositions
GB8917064D0 (en) * 1989-07-26 1989-09-13 Pfizer Ltd Antiparasitic agent
DE69126776T2 (de) 1990-03-05 1998-01-08 Mallinckrodt Veterinary, Inc., Terre Haute, Ind. Parasitizide zusammensetzung und verfahren zu ihrer herstellung und ihre verwendung
GB9121028D0 (en) 1991-10-03 1991-11-13 Pfizer Ltd Therapeutic agents
US5411737A (en) 1991-10-15 1995-05-02 Merck & Co., Inc. Slow release syneresing polymeric drug delivery device
GB9300883D0 (en) * 1993-01-18 1993-03-10 Pfizer Ltd Antiparasitic agents
JP3966479B2 (ja) * 1993-04-16 2007-08-29 日本テキサス・インスツルメンツ株式会社 ゾルーゲル法による強誘電体膜の形成方法及びキャパシタの製造方法
NZ266924A (en) * 1993-05-10 1997-09-22 Merck & Co Inc Pour-on avermectin insecticidal compositions containing glycerol or glycerides
TW327125B (en) * 1994-02-07 1998-02-21 Merck & Co Inc Composition and method for protecting against pine exhausted
GB9402916D0 (en) * 1994-02-16 1994-04-06 Pfizer Ltd Antiparasitic agents
DE19520275A1 (de) 1995-06-02 1996-12-05 Bayer Ag Endoparasitizide Mittel
TW362952B (en) 1996-01-30 1999-07-01 Takeda Chemical Industries Ltd Arylpyrazole insecticides
DE19612644A1 (de) 1996-03-29 1997-10-02 Bayer Ag Oxadiazin-Derivate
FR2753377B1 (fr) 1996-09-19 1999-09-24 Rhone Merieux Nouvelle association parasiticide a base de 1-n-phenylpyra- zoles et de lactones macrocycliques endectocides
GB9825402D0 (en) * 1998-11-19 1999-01-13 Pfizer Ltd Antiparasitic formulations
FI107528B (fi) 1998-12-23 2001-08-31 Kemira Chemicals Oy Menetelmä muurahaishapon valmistamiseksi

Also Published As

Publication number Publication date
CY1111955T1 (el) 2015-11-04
HK1040593B (zh) 2004-10-08
WO2000030449A1 (en) 2000-06-02
ATE469550T1 (de) 2010-06-15
OA11678A (en) 2005-01-12
BR9915458A (pt) 2001-07-17
HUP0104235A2 (hu) 2002-03-28
CA2351730A1 (en) 2000-06-02
BG65440B1 (bg) 2008-08-29
BR9915458B1 (pt) 2011-04-19
SI1130966T2 (sl) 2009-08-31
NZ510678A (en) 2003-08-29
ES2344505T3 (es) 2010-08-30
KR20010080505A (ko) 2001-08-22
PE20001319A1 (es) 2000-12-02
DE69942465D1 (de) 2010-07-15
HK1040593A1 (en) 2002-06-21
HRP20010368B1 (en) 2004-06-30
HRP20010368A2 (en) 2002-06-30
DE69923583T3 (de) 2009-12-24
GB9825402D0 (en) 1999-01-13
ID28698A (id) 2001-06-28
CN1326318A (zh) 2001-12-12
PT1130966E (pt) 2005-04-29
IL142104A (en) 2006-06-11
US6797701B2 (en) 2004-09-28
EA200100458A1 (ru) 2001-10-22
AU757892B2 (en) 2003-03-13
NZ537110A (en) 2006-04-28
HU229493B1 (en) 2014-01-28
AP1210A (en) 2003-09-30
TW526045B (en) 2003-04-01
BG105601A (en) 2002-01-31
EA003959B1 (ru) 2003-10-30
EP1130966B1 (en) 2005-02-02
UY25806A1 (es) 2001-08-27
ZA997174B (en) 2001-05-18
EP1130966B2 (en) 2009-05-27
DK1130966T4 (da) 2009-07-20
TNSN99213A1 (fr) 2005-11-10
IL173567A0 (en) 2006-07-05
SK6622001A3 (en) 2001-12-03
PA8485501A1 (es) 2000-09-29
MA25029A1 (fr) 2000-07-01
NO20012389D0 (no) 2001-05-15
KR100458406B1 (ko) 2004-11-26
AU5995999A (en) 2000-06-13
PL348638A1 (en) 2002-06-03
DK1130966T3 (da) 2005-05-09
CZ20011734A3 (cs) 2001-12-12
SI1522219T1 (sl) 2010-09-30
CZ304345B6 (cs) 2014-03-19
IL142104A0 (en) 2002-03-10
JP3507799B2 (ja) 2004-03-15
EP1522219A1 (en) 2005-04-13
DZ2945A1 (fr) 2004-03-15
SI1130966T1 (en) 2005-06-30
IS5907A (is) 2001-03-23
DE69923583D1 (de) 2005-03-10
DE69923583T2 (de) 2006-01-12
YU23401A (sh) 2005-06-10
AP9901697A0 (en) 1999-12-31
DK1522219T3 (da) 2010-08-16
CO5150175A1 (es) 2002-04-29
SK287540B6 (sk) 2011-01-04
GT199900197A (es) 2001-05-10
ATE288201T1 (de) 2005-02-15
PL204763B1 (pl) 2010-02-26
PT1522219E (pt) 2010-07-19
ES2237213T3 (es) 2009-08-19
JP2002530302A (ja) 2002-09-17
EP1522219B1 (en) 2010-06-02
EP1130966A1 (en) 2001-09-12
CA2351730C (en) 2006-12-05
CN1147232C (zh) 2004-04-28
US20020028780A1 (en) 2002-03-07
HUP0104235A3 (en) 2004-03-01
NO20012389L (no) 2001-05-15

Similar Documents

Publication Publication Date Title
AR023062A1 (es) Formulaciones antiparasitarias
ATE229802T1 (de) Zusammenstellung aus gemischten cyanoacrylatestern
ES2178298T3 (es) Compuestos anti-inflamatorios.
PT971705E (pt) Formulacoes de farmacos de terapeutica de substituicao hormonal para aplicacao topica na pele
ES2161085T3 (es) Formulaciones que contienen oxaliplatino.
AR007542A1 (es) Composicion
CL2004001129A1 (es) Compuestos derivados de halogenopirimidinas aril tio-eter; composicion pesticida; procedimiento de preparacion; compuestos intermediarios; y uso del compuesto como agente pesticida.
AU4046801A (en) Cosmetic composition, especially for use on aging and/or stressed skin
AR032872A1 (es) Composicion para aclarar la piel y el metodo de aplicacion
PT971708E (pt) Sistemas de gel de nimesulide para uso topico
HUP0302867A2 (hu) Paraziticid készítmények és alkalmazásuk
ES2115220T3 (es) Nuevo uso de compuestos bis-heterociclicos como agentes antiinflamatorios y composiciones farmaceuticas de los mismos.
ES2196737T3 (es) Asociacion de un retinoide con un derivado de histidina.
ES2147453T3 (es) Antagonistas de adenosina, procedimiento para su preparacion y su uso como medicamentos.
ES2129135T3 (es) Composiciones limpiadoras que contienen un alcanoato como acondicionador.
MX9207427A (es) Nuevos compuestos de ester de butilhidroxitolueno-omega-piridilo y composicion farmaceutica que los contiene.
BR9814495A (pt) Composto, processo para prepará-lo, uso do mesmo, composição farmacêutica, e, processo
TR199901374T2 (xx) B�cek �ld�r�c� ve mitisidal kompozisyonlar
PA8492001A1 (es) Composicion de resorcinol
ES2196645T3 (es) Composiciones transparentes para el cuidado de la piel.
DK1063969T3 (da) Topisk formulering af olie-i-vand type som en bærer til frembringelse af en reduceret irriteret effekt
TR200001604T2 (tr) Tarım formülasyonlarında çözücüler olarak yağlı alkol karbonatlarının kullanımı
AR014073A1 (es) Una composicion gelificada a base de jabon, de reducida irritacion cuando se aplica a la piel
JO2129B1 (en) A non-aqueous compound that repels intestinal worms
ES2175996T3 (es) Empleo de al menos un extracto de lipido obtenido del hueso de la fruta del ciruelo claudio.

Legal Events

Date Code Title Description
FG Grant, registration